Duloxetine is a serotonin and norepinephrine reuptake inhibitor (SNRI) with central nervous
system activity. Its analgesic efficacy in central pain is putatively related to its influence on …

Existing therapies for major depressive disorder (MDD) have either limited efficacy and/or
poor tolerability. The present study examined the effects of duloxetine, a potent and …

Study Design. A 14-week, randomized, double-blind, multicenter, placebo-controlled study
of Japanese patients with chronic low back pain (CLBP) who were randomized to either …

Background Currently, there are no medications approved for the treatment of juvenile
fibromyalgia (JFM). We evaluated the safety and efficacy of duloxetine 30/60 mg once daily …

Objective: Saffron was found efficient and safe in treatment of neuropsychiatric disorders, in
particular depression. We compared the efficacy of saffron with duloxetine in treatment of …

Objective The purpose of this study was to examine the relationship between the pain-
relieving effects of duloxetine and its plasma concentrations in patients with burning mouth …

OBJECTIVE: This analysis focuses on efficacy and safety data obtained from studies of
duloxetine for the treatment of major depressive disorder (MDD) within the approved dose …

Fibromyalgia syndrome is a chronic disease of widespread and debilitating pain whose
cause is unknown and whose risk factors are poorly understood. It is often comorbid with …

Introduction Duloxetine has demonstrated efficacy in chronic low back pain (CLBP). We
examined the predictors of response to duloxetine for CLBP. Patients and methods This was …

BACKGROUND: Fibromyalgia (FM) affects up to 6% of US adults, resulting in a significant
burden on the health care system and poor quality of life for patients. Duloxetine, pregabalin …